News & Events

Dr. Ralf Schittenhelm appointed as the new Director of the Monash Biomedical Proteomics Facility

22/09/2018

In January 2016, Dr. Ralf Schittenhelm was appointed as the new Director of the Monash Biomedical Proteomics Facility and succeeds Dr. Oded Kleifeld, who returned to Israel at the end of last year.

Prior to his arrival at Monash University in 2012, Ralf completed his PhD at the University of Zurich followed by a post doc at the Swiss Federal Institute of Technology (ETH Zurich). It was during his post doc that Ralf honed his skills in proteomics working alongside the likes of Rudi Aebersold.

Ralf is looking forward to this new role and is very interested in meeting anyone who wishes to apply proteomic-based technologies to address their research questions.

Upcoming Events

Save the date! The Australasian Proteomics Society (APS) is hosting their 24th Annual Lorne Proteomics Symposium from Thursday 7th to Sunday 10th February 2019 at the Cumberland Lorne Resort in Lorne, Victoria. The 24th Annual Lorne Proteomics Symposium will include a full day Metabolomics Symposium that will run concurrently with the main Proteomics meeting on Friday 8th February 2019 at Cumberland Lorne Resort.

Read more...

“The Omics Revolution: Towards Personalised Medicine” satellite meeting will be held at the 2017 Australian Peptides Conference. The workshop will be held at Peppers Noosa Resort on Sunday 15th October 2017 from 9am to 5pm prior to the start of the main meeting (registration will be free for all attendees of the main meeting). Additional satellite […]

Read more...

Terms & Conditions

Any information collected for PMV membership will be kept confidential and used only for PMV membership purposes. PMV is a non-profit organisation and will not share any personal or contact details with vendors or other external organisations.

Your membership details are essential for communication purposes. If the news check box is selected, PMV will send occasional emails alerting members to important events and PMV meetings.